{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:15:17Z","timestamp":1776352517653,"version":"3.51.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10096-025-05351-x","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T13:53:13Z","timestamp":1766497993000},"page":"967-976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Geographical trends of drug-resistant strains of Mycobacterium leprae in TLM hospitals: insights from a four-year study across eleven hospitals in eight Indian States"],"prefix":"10.1007","volume":"45","author":[{"given":"Rahul","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"5351_CR1","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/j.1365-4632.2011.05414.x","volume":"51","author":"XY Han","year":"2012","unstructured":"Han XY, Sizer KC, Velarde-F\u00e9lix JS, Frias-Castro LO, Vargas-Ocampo F (2012) The leprosy agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico. Int J Dermatol 51:952\u2013959. https:\/\/doi.org\/10.1111\/j.1365-4632.2011.05414.x","journal-title":"Int J Dermatol"},{"key":"5351_CR2","unstructured":"Weekly epidemiological record 13 SEPTEMBER (2024) 99th YEAR \/ 13 SEPTEMBRE 2024, 37, 2024, 99, 497\u2013552. http:\/\/www.who.int\/wer"},{"issue":"1","key":"5351_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4269\/ajtmh.18-0256","volume":"100","author":"T Narang","year":"2019","unstructured":"Narang T, Bishnoi A, Dogra S, Saikia UN (2019) Alternate anti-leprosy regimen for multidrug therapy refractory leprosy: a retrospective study from a tertiary care center in North India. Am J Trop Med Hyg 100(1):24\u201330. https:\/\/doi.org\/10.4269\/ajtmh.18\u20130256","journal-title":"Am J Trop Med Hyg"},{"key":"5351_CR4","unstructured":"Towards zero leprosy (2021) Global leprosy strategy 2021\u20132030. World Health Organization, Geneva. https:\/\/www.who.int\/publications\/i\/item\/9789290228509"},{"key":"5351_CR5","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.cmi.2018.02.022","volume":"24","author":"E Cambau","year":"2018","unstructured":"Cambau E, Saunderson P, Matsuoka M, Cole ST, Kai M, Suffys P et al (2018) Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009\u201315. ClinMicrobiol Infect 24:1305\u20131310. https:\/\/doi.org\/10.1016\/j.cmi.2018.02.022","journal-title":"ClinMicrobiol Infect"},{"key":"5351_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.47276\/lr.85.3.177","volume":"85","author":"M Lavania","year":"2014","unstructured":"Lavania M, Jadhav RS, Chaitanya VS, Turankar R, Selvasekhar A, Das L et al (2014) Drug resistance patterns in Mycobacterium leprae isolates from recurrenced leprosy patients attending the leprosy mission (TLM) hospitals in India. Lepr Rev 85:177\u2013185","journal-title":"Lepr Rev"},{"key":"5351_CR7","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/j.cmi.2015.08.004","volume":"21","author":"M Lavania","year":"2015","unstructured":"Lavania M, Nigam A, Turankar RP, Singh I, Gupta P, Kumar S et al (2015) Emergence of primary drug resistance to rifampicin in Mycobacterium leprae strains from leprosy patients in India. ClinMicrobiol Infect 21:e85\u2013e86. https:\/\/doi.org\/10.1016\/j.cmi.2015.08.004","journal-title":"ClinMicrobiol Infect"},{"key":"5351_CR8","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3201\/eid2408.180033","volume":"24","author":"DL Williams","year":"2018","unstructured":"Williams DL, Araujo S, Stryjewska BM, Scollard D (2018) Dapsone resistance in leprosy patients originally from American Samoa, united States, 2010\u20132012. Emerg Infect Dis 24:1584\u20131585. https:\/\/doi.org\/10.3201\/eid2408.180033","journal-title":"Emerg Infect Dis"},{"key":"5351_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4269\/ajtmh.19-0390","volume":"102","author":"NP Mahajan","year":"2020","unstructured":"Mahajan NP, Lavania M, Singh I, Nashi S, Preethish-Kumar V, Vengalil S et al (2020) Evidence for Mycobacterium leprae drug resistance in a large cohort of leprous neuropathy patients from India. Am J Trop Med Hyg 102:547\u2013552. https:\/\/doi.org\/10.4269\/ajtmh.19\u20130390","journal-title":"Am J Trop Med Hyg"},{"key":"5351_CR10","doi-asserted-by":"publisher","first-page":"e0217021","DOI":"10.1128\/aac.02170-21","volume":"66","author":"ESN Andrade","year":"2022","unstructured":"Andrade ESN, Brand\u00e3o JG, da Silva JS, Coriolano CRF, Rosa PS, Moraes MO et al (2022) Antimicrobial resistance among leprosy patients in brazil: real-world data based on the National surveillance plan. Antimicrob Agents Chemother 66:e0217021. https:\/\/doi.org\/10.1128\/aac.02170-21","journal-title":"Antimicrob Agents Chemother"},{"key":"5351_CR11","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.2147\/IDR.S368682","volume":"15","author":"Y Shi","year":"2022","unstructured":"Shi Y, Kong W, Jiang H, Zhang W, Wang C, Wu L et al (2022) Molecular surveillance of antimicrobial resistance of Mycobacterium leprae from leprosy patients in Zhejiang Province. China Infect Drug Resist 15:4029\u20134036. https:\/\/doi.org\/10.2147\/IDR.S368682","journal-title":"China Infect Drug Resist"},{"issue":"2","key":"5351_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4103\/0378-6323.152185","volume":"81","author":"AH Hasanoor Reja","year":"2015","unstructured":"Hasanoor Reja AH, Biswas N, Biswas S, Lavania M, Chaitanya VS, Banerjee S, Maha Patra PS, Gupta UD, Patra PK, Sengupta U, Bhattacharya B (2015) Report of RpoB mutation in clinically suspected cases of drug resistant leprosy: a study from Eastern India. Indian J Dermatol Venereol Leprol 81(2):155\u2013161. https:\/\/doi.org\/10.4103\/0378-6323.152185","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"5351_CR13","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/ced.12665","volume":"40","author":"D Liu","year":"2015","unstructured":"Liu D, Zhang Q, Sun Y, Wang C, Zhang Y, Fu X et al (2015) Drug resistance in Mycobacterium leprae from patients with leprosy in China. Clin Exp Dermatol 40:908\u2013911. https:\/\/doi.org\/10.1111\/ced.12665","journal-title":"Clin Exp Dermatol"},{"key":"5351_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jdermsci.2012.05.002","volume":"67","author":"S Mori","year":"2012","unstructured":"Mori S, Yotsu RR, Suzuki K, Makino M, Ishii N (2012) Present situation of leprosy in Japan, 2006\u20132010: analysis of drug resistance in treatment-naive registered and recurrenced cases by molecular biological methods. J Dermatol Sci 67:192\u2013194. https:\/\/doi.org\/10.1016\/j.jdermsci.2012.05.002","journal-title":"J Dermatol Sci"},{"key":"5351_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.7883\/yoken.63.412","volume":"63","author":"M Matsuoka","year":"2010","unstructured":"Matsuoka M, Suzuki Y, Garcia IE, Fafutis-Morris M, Vargas-Gonz\u00e1lez A, Car-re\u00f1o-Martinez C et al (2010) Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico. Jpn J Infect Dis 63:412\u2013416","journal-title":"Jpn J Infect Dis"},{"issue":"22","key":"5351_CR16","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.1016\/S2666","volume":"3","author":"S Marijke Braet","year":"2022","unstructured":"Marijke Braet S, Jouet A, Aubry A, Van Dyck-Lippens M, Lenoir E, Assoumani Y et al (2022) Investigating drug resistance of Mycobacterium leprae in the comoros: an observational deep-sequencing study. Lancet Microbe 3(22):e693\u2013700. https:\/\/doi.org\/10.1016\/S2666-","journal-title":"Lancet Microbe"},{"key":"5351_CR17","unstructured":"World Health Organization (2009) Guidelines for global surveillance of drug resistance in leprosy. WHO Regional Office for South-East Asia, New Delhi. https:\/\/apps.who.int\/iris\/handle\/10665\/205158"},{"key":"5351_CR18","doi-asserted-by":"publisher","first-page":"e0007946","DOI":"10.1371\/journal.pntd.0007946","volume":"13","author":"X Chen","year":"2019","unstructured":"Chen X, He J, Liu J, You Y, Yuan L, Wen Y (2019) Nested PCR and the TaqMan SNP genotyping assay enhanced the sensitivity of drug resistance testing of Mycobacterium leprae using clinical specimens of leprosy patients. PLoS Negl Trop Dis 13:e0007946. https:\/\/doi.org\/10.1371\/journal.pntd.0007946","journal-title":"PLoS Negl Trop Dis"},{"key":"5351_CR19","doi-asserted-by":"publisher","first-page":"1213.e5","DOI":"10.1016\/j.cmi.2018.06.004","volume":"24","author":"A Chauffour","year":"2018","unstructured":"Chauffour A, Lecorche E, Reibel F, Mougari F, Raskine L, Aubry A, Jarlier V, Cambau E, CNR-MyRMA (2018) Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015. Clin Microbiol Infect 24:1213.e5-1213.e8. https:\/\/doi.org\/10.1016\/j.cmi.2018.06.004","journal-title":"Clin Microbiol Infect"},{"key":"5351_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jgar.2017.10.010","volume":"12","author":"M Lavania","year":"2018","unstructured":"Lavania M, Singh I, Turankar R, Ahuja M, Pathak V, Sengupta U, Das L, Kumar A, Darlong J, Nathan R, Maseey A (2018) Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients. J Glob Antimicrob Resist 12:214\u2013219. https:\/\/doi.org\/10.1016\/j.jgar.2017.10.010","journal-title":"J Glob Antimicrob Resist"},{"key":"5351_CR21","doi-asserted-by":"publisher","first-page":"e0009382","DOI":"10.1371\/journal.pntd.0009382","volume":"15","author":"JAC Nery","year":"2021","unstructured":"Nery JAC, Sales AM, Hacker MAVB, Moraes MO, Maia RC, Sarno EN, Illarramendi X (2021) Low rate of relapse after twelve-dose multidrug therapy for Hansen\u2019s disease: a 20-year cohort study in a Brazilian reference center. PLoS Negl Trop Dis 15:e0009382. https:\/\/doi.org\/10.1371\/journal.pntd.0009382","journal-title":"PLoS Negl Trop Dis"},{"key":"5351_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.11606\/issn.2176-7262.v30i3p345-350","volume":"30","author":"DVA Opromolla","year":"1997","unstructured":"Opromolla DVA (1997) Leprosy therapy. Medicina, Ribeir\u00e3oPreto 30:345\u2013350. https:\/\/doi.org\/10.11606\/issn.2176-7262.v30i3p345-350","journal-title":"Medicina, Ribeir\u00e3oPreto"},{"key":"5351_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.4103\/idoj.idoj_599_21","volume":"12","author":"I Singh","year":"2021","unstructured":"Singh I, Sengupta U (2021) Drug resistance in Mycobacterium Leprae in the context of zero leprosy. Indian Dermatol Online J 12:791\u20135. https:\/\/doi.org\/10.4103\/idoj.idoj_599_21","journal-title":"Indian Dermatol Online J"},{"key":"5351_CR24","unstructured":"World Health Organization (2021) Anti-microbial resistance surveillance in leprosy: report of the virtual meeting. World Health Organization. https:\/\/www.who.int\/publications\/i\/item\/SEA- GLP- 7 [accessed 02.02.2024]Regional Office for South-East Asia"},{"issue":"20","key":"5351_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012443","volume":"23","author":"X Li","year":"2022","unstructured":"Li X, Li G, Yang J, Jin G, Shao Y, Li Y, Wei P, Zhang L (2022) Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: a Systematic Review and Meta-Analysis. Int J Mol Sci 23(20):12443. https:\/\/doi.org\/10.3390\/ijms232012443","journal-title":"Int J Mol Sci"},{"key":"5351_CR26","unstructured":"WHO (2009). Guidelines for global surveillance of drug resistance in leprosy. India:WHO"},{"key":"5351_CR27","unstructured":"Jadhav RS, Kamble RR, Shinde VS et al (2009) Use of reverse transcription polymerase chain reaction for the detection of Mycobacterium leprae in the slit-skin smears of leprosy patients. Indian J Lepr 2005;77:116\u2013127"},{"key":"5351_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.06561-11","author":"ADS Rocha","year":"2012","unstructured":"Rocha ADS, Cunha MDG, Diniz LM, Salgado C, Aires MAP, Nery JA, Gallo EN, Miranda A, Magnanini MMF, Matsuoka M, Sarno EN, Suffys PN, de Oliveira MLW (2012) Drug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients. J Clin Microbiol. https:\/\/doi.org\/10.1128\/jcm.06561-11","journal-title":"J Clin Microbiol"},{"issue":"4","key":"5351_CR29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.4103\/idoj.idoj_581_21","volume":"13","author":"R Jindal","year":"2022","unstructured":"Jindal R, Singh I, Bhardwaj S, Chauhan P (2022) High prevalence of resistance to anti-leprosy drugs in leprosy cases with chronic erythema nodosum leprosum: a matter of concern. Indian Dermatol Online J 13(4):511\u2013513. https:\/\/doi.org\/10.4103\/idoj.idoj_581_21","journal-title":"Indian Dermatol Online J"},{"key":"5351_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2017.10.010","author":"M Lavania","year":"2018","unstructured":"Lavania M, Singh I, Turankar RP, Ahuja M, Pathak V, Sengupta U, Das L, Kumar A, Darlong J, Nathan R, Maseey A (2018) Molecular detection of multidrug-resistant Mycobacterium lepraefrom Indian leprosy patients. J Glob Antimicrob Resist. https:\/\/doi.org\/10.1016\/j.jgar.2017.10.010","journal-title":"J Glob Antimicrob Resist"},{"issue":"5","key":"5351_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02170-21","volume":"17","author":"ESN Andrade","year":"2022","unstructured":"Andrade ESN, Brand\u00e3o JG, Silva JSD, Coriolano CRF, Rosa PS, Moraes MO, Ferreira CO, Gomes CM, Ara\u00fajo WN (2022) Antimicrobial resistance among leprosy patients in brazil: Real-World data based on the National surveillance plan. Antimicrob Agents Chemother 17(5):e0217021. https:\/\/doi.org\/10.1128\/aac.02170-21","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"5351_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/ijd.17470","volume":"64","author":"K Sardana","year":"2025","unstructured":"Sardana K, Muddebihal A, Scollard DM, Khurana A (2025) Implications of drug resistance in leprosy: disease course, reactions and the use of novel drugs. Int J Dermatol 64(2):302\u2013312. https:\/\/doi.org\/10.1111\/ijd.17470","journal-title":"Int J Dermatol"},{"key":"5351_CR33","unstructured":"World Health Organization. Guidelines for Surveillance of Drug Resistance in Leprosy. New Delhi: WHO Regional Office for South-East Asia (2017) ISBN: 9789290225492. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789290225492"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05351-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05351-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05351-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:33:55Z","timestamp":1776350035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05351-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5351"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05351-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}